Pathways’ Picks August 3: Medicare and Medtech, EU Picks, and More

article image
ARTICLE SUMMARY:

In this week’s roundup: CMS addresses new medtech in its inpatient payment rule; AdvaMed wants action on a novel tech coverage pathway; a new notified body and more EU MDR and IVDR updates; EPA eyes EtO; Medicare Advantage input sought; 3D-printing oversight, and updates from Brazil and Eurasia.

Medicare Picks

New medtech policies, payments:

New tech liaisons. CMS formalized its “new technology liaisons” program Aug. 1 in the FY 2023 hospital Inpatient Prospective Payment System (IPPS) final rule. “In order to streamline engagement by centralizing the different innovation pathways within CMS including new technology add-on payments, CMS has established a team of new technology liaisons that can serve as an initial resource for interested parties,” the rule states. The liaisons have their roots in a pilot program initiated by CMS in 2020 to help medtech developers, in particular start-ups, to navigate coverage, coding, and payment processes for technologies lacking well-worn reimbursement pathways. (See “CMS Restructures: New Office, Pilot Target Medtech,” Market Pathways, October 9, 2020.) The rule provides an email (MedicareInnovation@cms.hhs.gov) as a primary point of contact to request resources and coordination between various offices within CMS. The agency is also in the process of implementing the Medicare Electronic Application Request Information System (MEARIS) as a streamlined electronic intake system for new technology add-on payments, inpatient procedure category (MS-DRG) classification change requests, and ICD-10-PCS procedure code requests.

×

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?


Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.

All-Access

Questions?

We're here to help! Please contact us at: